Clinical Trials Directory

Trials / Completed

CompletedNCT04615767

D-chiro-inositol Increases Androgens and Reduces Estrogens in Human Serum

D-chiro-inositol, a Putative Aromatase Inhibitor, Increases Androgen and Reduces Estrogen Levels in Serum of Male Volunteers. A Pilot Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
AGUNCO Obstetrics and Gynecology Centre · Academic / Other
Sex
Male
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this pilot study is to test the effect of a 30 day-D-chiro-inositol oral treatment on a set of clinical parameters (mainly sex hormones) in a group of male volunteers selected by their age and BMI to investigate if D-chiro-inositol acts as an aromatase inhibitor.

Detailed description

This is an open label clinical trial with a dietary supplement carried out in male volunteers selected by their age and BMI. The aim is to test the effect of oral daily treatment with 1 g D-chiro-inositol for 30 days on some clinical parameters, to see if D-chiro-inositol acts as an aromatase inhibitor. Testosterone, estradiol, Testosterone/Estradiol ratio, Dehydroepiandrosterone sulfate, Estrone, glycemia and insulinemia (with calculation of HOMA index), follicle-stimulating hormone, Luteinizing hormone, D-chiro-inositol and Myo-inositol serum concentrations have to be determined before and after D-chiro-inositol administration. We wish to evaluate if this treatment for one month is able to change the sexual hormone levels, increasing androgens and decreasing estrogens. Furthermore, we wish to control the safety profile of D-chiro-inositol, a well-known molecule, different from the classic aromatase inhibitors. We think that our pilot study can open up new perspectives of research and therapeutic applications for this many-sided molecule.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTD-chiro-inositolas described previously

Timeline

Start date
2020-10-28
Primary completion
2020-12-06
Completion
2020-12-16
First posted
2020-11-04
Last updated
2021-08-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04615767. Inclusion in this directory is not an endorsement.